837 related articles for article (PubMed ID: 18379139)
1. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive models for predicting histology in patients with chronic hepatitis B.
Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
4. New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis.
Wang HW; Peng CY; Lai HC; Su WP; Lin CH; Chuang PH; Chen SH; Chen CH; Hsu WF; Huang GT
Sci Rep; 2017 Jun; 7(1):3259. PubMed ID: 28607450
[TBL] [Abstract][Full Text] [Related]
5. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
[TBL] [Abstract][Full Text] [Related]
7. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
10. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis.
Chrysanthos NV; Papatheodoridis GV; Savvas S; Kafiri G; Petraki K; Manesis EK; Archimandritis AJ
Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):389-96. PubMed ID: 16538110
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
[TBL] [Abstract][Full Text] [Related]
12. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
[TBL] [Abstract][Full Text] [Related]
15. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice.
Giannini EG; Zaman A; Ceppa P; Mastracci L; Risso D; Testa R
J Clin Gastroenterol; 2006 Jul; 40(6):521-7. PubMed ID: 16825935
[TBL] [Abstract][Full Text] [Related]
16. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
17. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C.
Pokorska-Śpiewak M; Kowalik-Mikołajewska B; Aniszewska M; Pluta M; Marczyńska M
BMC Infect Dis; 2017 May; 17(1):361. PubMed ID: 28535787
[TBL] [Abstract][Full Text] [Related]
18. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
19. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of AST to platelet ratio index in predicting severe hepatic fibrosis and cirrhosis in chronic hepatitis B virus infection].
Sim SJ; Cheong JY; Cho SW; Kim JS; Lim TY; Shin DH; Lim SG; Kim YB; Lee KM; Yoo BM; Lee KJ; Hahm KB; Kim JH
Korean J Gastroenterol; 2005 May; 45(5):340-7. PubMed ID: 15908767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
